31.01.2023 - 02.02.2023Omni Parker House, 60 School Street, 02108 Boston, Massachusetts, USA
Time: 9:00 am - 4:30 pm
Temas de la conferencia As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability.
Speakers: Rajiv Gangurde | Chief Technology Officer | SparingVision, Susan D'Costa | Executive VP and Global Head, Technology | Alcyone Therapeutics, and more.
